Respiratory Flashcards
(112 cards)
What is asthma?
What are the 3 factors that contribute to airway narrowing?
A chronic inflammatory disorder of lung airways, characterised by airway hyperresponsiveness leading to bronchospasm and reversible airway obstruction.
-Reversible airway narrowing
- Bronchial muscle contraction (spasm) –> hypersensitive airways react to variety of stimuli e.g exercise, cold air
- Inflammation of mucous membranes
- Increased mucous production and secretions
What are the main two types of asthma?
- Eosionophilic –> atopy/allergic asthma. Type 1 hypersensitivity. Associated w genetic tendency of immune system to produce IgE in response to common environmental allergens e.g pets, pollens
- Non-eosinophilic —> Not associated w allergy. Thought to involve more local immune response, involves neutrophil recruitment in airways.
What are the RF for asthma?
- FH or PMH of hayfever, eczema, food allergies, drug allergies. Exposure to dust, fumes, allergens such as occupational dust (type 3 hypersensitivity) or pets.
- Provoking features –> allergens, infections, menstrual cycle, cold air, emotion
- Onset in childhood common,
- 20s-70s onset w no allergies –> late onset non atopic
What is the typical presentation of asthma?
- Intermittent SOB
- Dry cough –> worse at night and in morning –> Diurnal
- Episodic wheeze
- Morning chest tightness
- Diurnal variation of symptoms, worse 3-5 morning
- Precipitant e.g exercise
-In children –> cough wheezing, may describe tight chest as tummy ache. Ask about premature birth, low birth weight, previous bronchiolitis or croup
What are the 1st line and gold standard investigations for asthma?
GOLD STANDARD –> exhaled nitric oxide. Fraction of exhaled nitric oxide >40ppb +ve for asthma. Leverl in breath, produced to fight inflamm –> muscle relaxant. Normal <25 adults, <20 children.
1st line –> Spirometry w reversibility. FEV1/FVC ratio <70% adults <85% children. Reversibility testing –> asthma suggested by larger >400ml response to bronchodilators or prednisolone. FEV1 increase 12% and increase 200ml volume.
Alternative when spirometry not available –> peak flow –> PEFR reduced in asthma. Peak flow meter and diary 2-4 weeks aid diagnosis. 20% diurnal variation >3 days a week for two weeks –> typical asthma. Compare to expected values e.g age, gender, height.
-Children <5 can’t perform spirometry –> clinical diagnosis, trial treatment e.g low dose ICS,
What is the management for asthma in adults?
What are the features that mean asthma is not being controlled?
Aim –> No daytime symptoms, no night time waking, no need for resuce medicaiton, no limitations ADL, no attacks.
Step wise –> Move up and down as needed
1 –> SABA as required for symptom relief. More than OD or night time symptoms –> step 2. Most patients start step 2.
2 –> Add low dose ICS. Beclomethasone, budesomide.
3 –> Add LTRA. Montelukast. Check patients adherence and inhaler technique.
4 –> Add LABA. Salmeterol. W or w/o LTRA depends whether effective.
5 –> Low dose ICS w LABA in MART regimen. Symbicort.
6 –> Increase ICS to moderate.
7 –> Increase ICS to high. Refer to specialist.
MART –> Maintenance and reliever therapy. Combined ICS and LABA in one inhaler.
-Severe eosinophilic –> biologic therapies. Anti IgE –> omalizumab –> removes IgE allergy Ab. £30,000 per year.
What is the management for asthma in over 5’s - 16s?
1 --> SABA 2 --> Low dose ICS and LTRA 3 --> Stop LTRA, add LABA 4 --> MART 5 --> Moderate dose ICS 6 --> High dose ICS specialist
What is the management for asthma in under 5’s?
1 --> SABA 2 --> Low dose ICS 3 --> Moderate dose ICS 4 --> Add LTRA 5 --> Stop LTRA, specialist
What is a severe asthma attack and how should it be managed?
Severe Any one of
- PEFR 33-50% predicted
- RR >25
- Hr >110
- Inability to complete sentences
What are the differences in presentation COPD v asthma?
- COPD rarely <35s, asthma commonly children
- COPD 85% history smoking. Asthma varies.
- Both w cough, COPD productive and sputum. Asthma nocturnal.
- Both SOB, COPD persistent, asthma intermittent.
- Night time waking in asthma not COPD.
- Asthma diurnal and day to day variation. COPD continual and progressive symptoms.
- Spirometry w reversibility –> asthma yes, COPD no.
What is COPD?
- Progressive airway obstruction w little or no reversibility. Characterised by infiltration of neutrophils.
- Encompasses chronic bronchitis and emphysema.
Bronchitis
- Hypertrophy and hyperplasia of mucous secreting glands, inflamm of bronchial tubules, airway narrowing and subsequent obstruction.
- Chronic bronchitis –> productive couhg >3 months in two consecutive years, can produce large amounts sputum.
Emphysema
-Destruction of lung parenchyma w dilation f alveolar airspaces w loss of elastic recoil and air trapping.
-Patients w COPD divide into those w predominant breathlessness (emphysema) or predominant exacerbations (chronic bronchitis).
What are the risk factors for COPD?
- Age >35, middle age
- Smoking of history of smoking 85%
- Occupation exposure e.g dust
- FH alpha 1 antitrypsin deficiency –> younger patients
- Provoking factors infections and cold air
What is the typical presentation of COPD?
What is the presentation of an acute excerbation?
-Acute exacerbation –> worsening previously stable COPD, beyond day to day variation. Mya be due to viral or bacterial infection. Increase SOB, sputum volume and purulence.
- History of several months of progressive worsening of symptoms –> exertional SOB, chronic cough and sputum
- SOB, chronic cough, regular sputum production, frequent winter bronchitis, wheeze.
- Tachypnoea, use accessory muscles, may be cyanosis.
- May be weightloss –> hard to breath when eat
What are the 1st line and gold standard investigations for COPD?
1st line and GOLD standard –> spirometry w reversibility testing.
- Airway obstruction defined as <80% predicted and a reduced FEV1/FVC ratio <0.7/70%.
- Reversibility –> spirometry before and after dose of inhaled bronchodilator.
- Clinically significant not present when FEV1 and FEV1/FVC ratio return to normal.
- CXR –> may show hyperinflation
- ECG –> r/o features cardiac disease e.g HF
What is ACCOS?
- Think when patients also have features of asthma, treat those w ACCOS as those w recurrent exacebations.
- Common variable airflow obstruction but not completely reversible
What is the staging for COPD?
Stage by FEV1
- Stage 1 –> mild >80%
- Stage 2 –> moderate –> 50-79%
- Stage 3 –> Severe –> 30-49%
- Stage 4 –> <30%
What is the MRC dyspnoea scale?
Measures impact of SOB on patient
1 –> SOB on exertion
2 –> SOB up hills or walking quickly
3 –> Walks slower or stop on flat as SOB
4 –> Exercise tolerance 100-200 yards on flat
5 –> Housebound, SOB on minor tasks
What is the medical management for COPD?
Step 1 –> breathless and exercise limitation –> SABA PRN. Continue at all steps.
Step 2 –> Still symptomatic, combination inhaler
- Predominant breathlessness (emphysema) –> LABA (salmeterol) AND LAMA (tiotropium)
- Two or more exacerbations in last 12 months of previous history of confirmed asthma –> ICS and LABA
Step 3 –> Ongoing excaberations (2 or more in 6 months) or admission to hospital.
-Triple therapy –> ICS and LABA and LAMA.
Step 4
-Still symptomatic –> consider theophylline
What are the other interventions in COPD?
- Smoking cessation advice –> only disease modifying treatment that slows FEV/FVC decline.
- Pulmonary rehabilitation
- Exercise –> exercise training programme –> increases tolerance and improves SOB
- Vaccinations –> flu and pneumococcal
- Mucolytics in those w heavy mucous production
- Long term oxygen therapy in severe COPD causing hypoxia and cyanosis.
- Antidepressants when needed
How should exacerbations of COPD be treated?
What should be done when there is no improvement in symptoms?
- Increase dose of SABA
- Exacerbation and sputum purulence –> Ab 1st line doxycycline. Alternative amoxicillin. PA clarithromycin.
- Oral corticosteroid –> prednisolone 30mg OD 1-2 weeks.
No improvement in symptoms on first choice for 2-3 days
- Send a sputum sample for culture and susceptibility testing.
- Offer an alternative first choice antibiotic from different class (guided by susceptibilities when available).
If the person is at higher risk of treatment failure e.g frequent antibiotic use, previous or current sputum culture with resistant bacteria or high risk of developing complications)
-Consider prescribing co-amoxiclav 500/125 mg TDS 5 days
What is sleep apnoea?
What are the RF?
- Intermittent closure/collapse of the pharyngeal air way causing apnoeic episodes during sleep. These are terminated by partial arousal.
- Upper airway obstruction –> episodes apnoea >10 seconds without breathing, usually hundreds in night. –Causes frequent waking, giving sawtooth pattern sleep.
- 90% due to pharyngeal obstruction from large neck particularly >40cm circumference.
- Common in obesity.
- Others due to retrognathia (setback mandible) or enlarged tonsils in children.
- 1 in 4 when BMI >30
- RF –> obesity, age, male, alcohol, smoking, hypothyroidism
What is the typical history and presentation of sleep apneoa?
- Loud snoring. Snoring gasping and choking during sleep.
- Daytime somnolence.
- Poor sleep quality.
- Morning headache.
- Decreased libido.
- Nocturia.
- Decrease cognitive performance.
- Increase risk HTN
What are the investigations for sleep apnoea?
What is the diagnostic test?
- Simple studies –> pulse oximetry and video recordings can be all that’s needed to diagnose
- Epworth sleepiness scale –> initial screen >10 –> referral sleep service
- Neck circumference and BMI. Check nasal patency, tongue size, oropharynx for large tonsils or other obstructions.
- BP and glucose
- DIAGNOSTIC TEST –> Polysomonography –> which monitors oxygen saturation, airflow at the nose and mouth, ECG, EMG chest, and abdominal wall movement during sleep. Can be attended or non attended. Apnoea-hypopnea index and scores, >5 mild, >15 moderate, >30 severe. The occurrence of 15 or more episodes of apnoea or hypopnoea during 1h of sleep, on average, indicates significant sleep apnoea.
What is the management for sleep apnoea?
- Lifestyle –> lose weight, avoidance of tobacco and alcohol.
- Sleep hygiene –> avoid sedatives in evening including alcohol and advise sleeping on side.
- Inform DVLA when OSA and symptomatic w day time sleepiness. Can drive as long as treatment effective.
- 1st line for symptomatic OSA effective QOL –> Nocturnal continuous positive airway pressure CPAP –> CPAP via a nasal mask during sleep is effective and recommended by NICE for those with moderate to severe disease. Often lifelong.
- Surgery to relieve pharyngeal or nasal obstruction, eg tonsillectomy or polypectomy, is occasionally needed.